Simona Fioriti
Overview
Explore the profile of Simona Fioriti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fioriti S, Pallotta F, DAchille G, Cirioni O, Simonetti O, Neubauer D, et al.
Microbiol Spectr
. 2025 Feb;
:e0178624.
PMID: 40013777
has increasingly become a global threat due to its wide range of antifungal resistances as well as its ability to sustain outbreaks in clinical settings. Two lipopeptides, C14-NleRR-NH (Nel) and...
2.
DAchille G, Nunzi I, Fioriti S, Cirioni O, Brescini L, Giacometti A, et al.
J Glob Antimicrob Resist
. 2024 Jul;
38:339-340.
PMID: 39032696
No abstract available.
3.
Caggiano G, Fioriti S, Morroni G, Apollonio F, Triggiano F, DAchille G, et al.
J Infect Public Health
. 2024 Apr;
17(6):967-974.
PMID: 38631066
Background: Candidemia is the most common healthcare associated invasive fungal infection. Over the last few decades, candidemia caused by Candida species other than Candida albicans, particularly the Candida parapsilosis complex,...
4.
Brescini L, Fioriti S, Coccitto S, Cinthi M, Mingoia M, Cirioni O, et al.
Microb Drug Resist
. 2023 May;
29(9):388-391.
PMID: 37222764
Although coagulase negative staphylococci are rarely associated with complicated diseases, in some cases they cause life-threatening infections. Here we described a clinical case of a bacteremia due to a methicillin-...
5.
Fioriti S, Brescini L, Pallotta F, Canovari B, Morroni G, Barchiesi F
J Fungi (Basel)
. 2022 Oct;
8(10).
PMID: 36294642
Candida spp. is the major causative agent of fungal infections in hospitalized patients and the fourth most common cause of nosocomial bloodstream infection (BSI). The availability of standardized methods for...
6.
Fioriti S, Cirioni O, Simonetti O, Franca L, Candelaresi B, Pallotta F, et al.
J Fungi (Basel)
. 2022 Aug;
8(8).
PMID: 36012859
Aspergillosis, which is mainly sustained by , includes a broad spectrum of diseases. They are usually severe in patients with co-morbidities. The first-line therapy includes triazoles, for which an increasing...
7.
Morroni G, Brescini L, Antonelli A, Di Pilato V, Castelletti S, Brenciani A, et al.
J Glob Antimicrob Resist
. 2022 Jul;
30:377-383.
PMID: 35842115
Objectives: Ceftolozane/tazobactam (C/T) is a novel cephalosporin and β-lactamase inhibitor combination with great activity against Pseudomonas aeruginosa. To assess P. aeruginosa susceptibility to C/T, a surveillance study was conducted from...
8.
Cinthi M, Coccitto S, DAchille G, Morroni G, Simoni S, Fioriti S, et al.
J Glob Antimicrob Resist
. 2022 Jul;
30:308-310.
PMID: 35830951
No abstract available.
9.
Morroni G, Bressan R, Fioriti S, DAchille G, Mingoia M, Cirioni O, et al.
Antibiotics (Basel)
. 2022 Apr;
11(4).
PMID: 35453287
Results have been implemented with additional data, which have been commented in the following paragraphs [...].
10.
Coccitto S, Cinthi M, Fioriti S, Morroni G, Simoni S, Vignaroli C, et al.
J Antimicrob Chemother
. 2022 Jan;
77(2):331-337.
PMID: 35076077
Objectives: To characterize a linezolid-resistant Enterococcus gallinarum isolate of porcine origin co-carrying cfr, optrA and poxtA genes. Methods: The genome was sequenced using the Illumina and Nanopore platforms. The presence...